Bioreactors Market Size, Share, Growth Analysis, By Materials (Glass, Stainless Steel), By Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), By Control Type (Manual, and Automated) By Region - Industry Forecast 2024-2031

Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024–2031).

The bioreactor market is extremely competitive in nature due to the combination of prominent global and smaller and medium-sized companies. These organizations are all striving to increase their market share. Companies are also constantly focusing on innovations like automation and process control, integrated sensors and analytics, high-density cell cultures, and hybrid bioreactors. Furthermore, the market leaders are efficiently leading this dynamic setting with advancements through massive investments in research and development. Focus on strategic alliances, acquisitions, and mergers are also playing a vital part in the growth of the bioreactors market. 'Sartorius AG (Germany) ', 'Thermo Fisher Scientific Inc. (U.S.) ', 'General Electric (U.S.) ', 'Eppendorf AG (Germany) ', 'Merck KGaA (Germany) ', 'Pall Corporation (U.S.) ', 'ZETA (India) ', 'PRaj Hipurity Systems Limited (India) ', 'Bioengineering AG (Switzerland) ', 'Infors AG (Switzerland) ', 'Solaris Biotechnology Srl. (Donaldson Company) (Italy) ', 'Bbi Biotech (Germany) ', 'Shanghai Bailun Biotechnology co., Ltd. (China) ', 'PBS Biotech Inc. (U.S.) ', 'CerCell A/S (Denmark) ', 'GEA Group Aktiengesellschaft (Germany) ', 'M+W Group (Germany) ', 'Technip S.A. (France) ', 'Jacobs Engineering Group Inc. (U.S.)'

For manufacturing various kinds of vaccines that plays an important part in mitigative several diseases are driving the growth of the market. Lately, the outbreak of COVID-19 pandemic increased the demand for COVID vaccines, resulting in high requirement for bioreactors of the clinical stage. In such situations, bioreactors are massively adopted in different pharmaceutical companies to successfully introduce preventive vaccines in the market.

Increasing Technological Development: Continuous Innovations in the characteristics of the bioreactors and the processing of bioreactors are propelling market growth. Active involvement of manufacturers in creating advanced technology will offer cost-efficient bioreactors and assist in the production of massive amount of items. This is increasing the growth of the bioreactors market. There are also various advantages of using advanced bioreactors and these will help in generating more revenue in the market.

North America is dominating the bioreactors market with maximum market revenue. This dramatic surge in the market is mainly due to the presence of well-known manufacturers leading the market in the region. Moreover, there is also an increase in the number of patients suffering from chronic diseases along with the growth in geriatric population. These are increasing the demand for bioreactors in the market. Private and public facilities are also making massive investment in research and development activities for introducing new and advanced products, driving the growth of the market. The facilities offered for conducting research and development have advanced infrastructure to smoothen complex research activities. This research is also being supported by government as the demand for different types of vaccines have increased. These are propelling the growth of bioreactors market in North America.